Identification of Primary and Secondary Measles Vaccine Failures by Measurement of Immunoglobulin G Avidity in Measles Cases during the 1997 São Paulo Epidemic

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 1, 2004, Pages 119-122

  Pannuti, Cláudio S ^a   Morello, Ricardo José ^a   De Moraes, José Cássio ^b   Curti, Suely Pires ^c   Afonso, Ana Maria S ^c   Camargo, Maria Cláudia Corrêa ^b   De Souza, Vanda A U F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Secretaria da Saude do Estado de Sao Paulo   (Brazil)

^c INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; MEASLES VACCINE;

ADOLESCENT; ADULT; ANTIBODY AFFINITY; ARTICLE; BRAZIL; CHILD; EPIDEMIC; HUMAN; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; SEROCONVERSION; TREATMENT FAILURE;

EID: 0346497857     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.1.119-122.2004     Document Type: Article

References (31)

1. Akingbade, D., B. J. Cohen, and D. W. Brown. 2003. Detection of low-avidity immunoglobulin G in oral fluid samples: a new approach for rubella diagnosis and surveillance. Clin. Diagn. Lab. Immunol. 10:189-190.
2. Baccard-Longere, M., F. Freymuth, D. Cointe, J. M. Seigneurin, and L. Grangeot-Keros. 2001. Multicenter evaluation of a rapid and convenient method for determination of cytomegalovirus immunoglobulin G avidity. Clin. Diagn. Lab. Immunol. 8:429-431.
3. Black, F. L., L. L. Berman, M. Libel, C. A. Reichelt, F. D. Pinheiro, A. Travassos da Rosa, F. Figueira, and E. Siqueira Gonzales. 1984. Inadequate immunity to measles in children vaccinated at an early age: effect of revaccination. Bull. W. H. O. 62:315-319.
4. Camargo, M. C., J. C. Moraes, V. A. Souza, M. R. Matos, and C. S. Pannuti. 2000. Predictors related to the occurrence of a measles epidemic in the city of Sao Paulo in 1997. Pan. Am. J. Public Health 7:359-365.
5. Centers for Disease Control and Prevention. 1991. Measles. United States, 1990. Morb. Mortal. Wkly. Rep. 40:369-372.
6. Centers for Disease Control and Prevention. 1998. Progress toward elimination of measles from the Americas. Morb. Mortal. Wkly. Rep. 47:189-193.
7. Chen, R. T., L. E. Markowitz, P. Albrecht, J. A. Stewart, L. M. Mofenson, S. R. Preblud, and W. A. Orenstein. 1990. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162:1036-1042.
8. Condorelli, F., A. Stivala, R. Gallo, E. Musumeci, M. C. Scata, L. Strano, M. Pennisi, G. Russo, A. Castro, and G. Scalia. 1997. Improvement in establishing the period of rubella virus primary infection using a mild protein denaturant. J. Virol. Methods 66:109-112.
9. Edmonson, M. B., D. G. Addiss, J. T. McPherson, J. L. Berg, S. R. Circo, and J. P. Davis. 1990. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA 263:2467-2471.
10. Erdman, D. D., J. L. Heath, J. C. Watson, L. E. Markowitz, and W. J. Bellini. 1993. Immunoglobulin M antibody response to measles virus following-primary and secondary vaccination and natural virus infection. J. Med. Virol. 1:44-48.
11. Erdman, D. D., L. J. Anderson, D. R. Adams, J. A. Stewart, L. E. Markowitz, and W. J. Bellini. 1991. Evaluation of monoclonal antibody-based capture enzyme immunoassays for detection of specific antibodies to measles virus. J. Clin. Microbiol. 29:1466-1471.
12. Hayden, G. F. 1979. Measles vaccine failure. A survey of causes and means of prevention. Clin. Pediatr. 18:155-167.
13. Hedman, K., M. Lappalainen, M. Söderlund, and L. Hedman. 1993. Avidity of IgG in serodiagnosis of infectious diseases. Rev. Med. Microbiol. 4:123-129.
14. Hedman, K., and S. A. Rousseau. 1989. Measurement of avidity of specific IgG for verification of recent primary rubella. J. Med. Virol. 27:288-292.
15. Helfand, R. F., J. L. Heath, L. J. Anderson, E. F. Maes, D. Guris, and W. J. Bellini. 1997. Diagnosis of measles with an IgM capture EIA: the optimal timing of specimen collection after rash onset. J. Infect. Dis. 175:195-199.
16. Hidaka, Y., T. Aoki, M. Akeda, C. Miyazaki, and K. Ueda. 1994. Serological and clinical characteristics of measles vaccine failure in Japan. Scand. J. Infect. Dis. 26:725-730.
17. Hummel, K. B., D. D. Erdman, J. Heath, and W. J. Bellini. 1992. Baculovirus expression of the nucleoprotein gene of measles virus and utility of the recombinant protein in diagnostic enzyme immunoassays. J. Clin. Microbiol. 30:2874-2880.
18. Kano, A., and Y. Kazuyama. 2002. Immunoglobulin G antibody avidity assays for serodiagnosis of hepatitis C virus infection. J. Med. Virol. 68:229-233.
19. Markowitz, L. E., S. R. Preblud, P. E. Fine, and W. A. Orenstein. 1990. Duration of live measles vaccine-induced immunity. Pediatr. Infect. Dis. J. 9:101-110.
20. Mathias, R. G., W. G. Meekison, T. A. Arcand, and M. T. Schechter. 1989. The role of secondary vaccine failures in measles outbreaks. Am. J. Public Health 79:475-478.
21. Montoya, J. G., O. Liesenfeld, S. Kinney, C. Press, and J. S. Remington. 2002. VIDAS test for avidity of toxoplasma-specific immunoglobulin G for confirmatory testing of pregnant women. J. Clin. Microbiol. 40:2504-2508.
22. Nossal, G. J. V. 1992. The molecular and cellular basis of affinity maturation in antibody response. Cell 68:1-2.
23. Ozanne, G., and M. A. d'Halewyn. 1992. Secondary immune response in a vaccinated population during a large measles epidemic. J. Clin. Microbiol. 30:1778-1782.
24. Paunio, M., H. Peltola, M. Valle, I. Davidkin, M. Virtanen, and O. P. Heinonen. 1999. Twice-vaccinated recipients are better protected against epidemic measles than are single-dose recipients of measles containing vaccine. J. Epidemiol. Commun. Health 53:173-178.
25. Paunio, M., K. Hedman, I. Davidkin, M. Valle, O. P. Heinonen, P. Leinikki, A. Salmi, and H. Peltola. 2000. Secondary measles vaccine failures identified by measurement of IgG avidity: high occurrence among teenagers vaccinated at a young age. Epidemiol. Infect. 124:263-271.
26. Paunio, P., K. Hedman, I. Davidkin, and H. Peltola. 2003. IgG avidity to distinguish secondary from primary measles vaccination failures: prospects for a more effective global measles elimination strategy. Exp. Opin. Pharmacother. 4:1215-1225.
27. Revello, M. G., and G. Gerna. 2002. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin. Microbiol. Rev. 15:680-715.
28. Reyes, M. A., M. F. Borrero, J. Roa, G. Bergonzoli, and N. G. Saravia. 1987. Measles vaccine failure after documented seroconversion. Pediatr. Infect. Dis. J. 6:848-851.
29. Robertson, P., S. Beynon, R. Whybin, C. Brennan, U. Vollmer-Conna, I. Hichie, and A. Lloyd. 2003. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection. 2003. J. Med. Virol. 70:617-623.
30. Souza, V. A. U. F., C. S. Pannuti, L. M. Sumita, and P. Albrecht. 1991. Enzyme-linked immunosorbent assay (ELISA) for measles antibody. A comparison with haemagglutination inhibition, immunofluorescence and plaque neutralization tests. Rev. Inst. Med. Trop. Sao Paulo 33:32-36.
31. Souza, V. A. U. F., C. S. Pannuti, L. M. Sumita, and H. F. Andrade, Jr. 1997. Enzyme-linked immunosorbent assay-IgG antibody avidity test for single sample serologic evaluation of measles vaccines. J. Med. Virol. 52:275-279.